NASDAQ:HLTH

Cue Health (HLTH) Stock Forecast, Price & News

$0.59

+0.06 (+11.25%)

(As of 06/6/2023 ET)

Compare

Today's Range: $0.51
▼
$0.64
50-Day Range: $0.53
▼
$1.88
52-Week Range: $0.51
▼
$5.34

Volume: 2.34 million shs
Average Volume: 400,618 shs
Market Capitalization: $89.99 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.20

Cue Health MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 944.7% Upside
$6.20 Price Target
Short Interest: Bearish
2.92% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.04
Based on 7 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.96) to ($1.33) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.95 out of 5 stars

Medical Sector

489th out of 981 stocks

Analytical Instruments Industry

15th out of 27 stocks

3.3

Analyst's Opinion

Consensus Rating
Cue Health has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $6.20, Cue Health has a forecasted upside of 944.7% from its current price of $0.59.
Amount of Analyst Coverage
Cue Health has only been the subject of 1 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
2.92% of the float of Cue Health has been sold short.
Short Interest Ratio / Days to Cover
Cue Health has a short interest ratio ("days to cover") of 7.3.
Change versus previous month
Short interest in Cue Health has recently increased by 2.41%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Cue Health does not currently pay a dividend.
Dividend Growth
Cue Health does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HLTH.

1.6

News and Social Media Coverage

News Sentiment
Cue Health has a news sentiment score of -0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Cue Health this week, compared to 1 article on an average week.
Search Interest
2 people have searched for HLTH on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Cue Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cue Health insiders have not sold or bought any company stock.
Percentage Held by Insiders
12.50% of the stock of Cue Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
44.63% of the stock of Cue Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Cue Health are expected to grow in the coming year, from ($1.96) to ($1.33) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cue Health is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cue Health is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cue Health has a P/B Ratio of 0.15. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Cue Health (NASDAQ:HLTH) Stock

Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Receive HLTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cue Health and its competitors with MarketBeat's FREE daily newsletter.

HLTH Stock News Headlines

June 6, 2023 | msn.com

FDA approves Cue Health's at-home COVID-19 test

June 6, 2023 | reuters.com

US FDA approves Cue Health's at-home COVID test

June 6, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

June 6, 2023 | finance.yahoo.com

Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test

June 5, 2023 | msn.com

Expert Ratings for Cue Health

June 3, 2023 | americanbankingnews.com

Cue Health (NASDAQ:HLTH) vs. Talis Biomedical (NASDAQ:TLIS) Financial Review

June 2, 2023 | americanbankingnews.com

Cue Health (NASDAQ:HLTH) Lowered to Neutral at The Goldman Sachs Group

May 29, 2023 | finance.yahoo.com

Cue Health Inc. (HLTH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

June 6, 2023 | Altimetry (Ad)

Biden's latest bailout--terrible for America?

And a consultant for the Dept. of Defense (Joel Litman) says this is all leading to an event in the next 20 months that could help some get vastly wealthier… but also make it harder than ever to hang onto any money you make.This might be the most important development affecting you and your money over the next few years—

May 19, 2023 | americanbankingnews.com

BTIG Research Trims Cue Health (NASDAQ:HLTH) Target Price to $3.00

May 17, 2023 | finance.yahoo.com

Cue Health Inc. (HLTH) Loses -47.82% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

May 17, 2023 | finance.yahoo.com

Cue Health Inc. (HLTH) Upgraded to Buy: Here's What You Should Know

May 13, 2023 | finance.yahoo.com

Cue Health Inc. (NASDAQ:HLTH) Q1 2023 Earnings Call Transcript

May 11, 2023 | msn.com

Recap: Cue Health Q1 Earnings

May 11, 2023 | markets.businessinsider.com

Cue Health earnings preview: what Wall Street is expecting

May 9, 2023 | msn.com

Earnings Preview: Cue Health

May 9, 2023 | finance.yahoo.com

Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test

May 4, 2023 | americanbankingnews.com

Cue Health Inc. (NASDAQ:HLTH) Sees Significant Decline in Short Interest

April 27, 2023 | seekingalpha.com

HLTH Cue Health Inc.

April 26, 2023 | finance.yahoo.com

Cue Health to Announce First Quarter 2023 Financial Results

March 31, 2023 | americanbankingnews.com

Financial Analysis: Standard BioTools (NASDAQ:LAB) vs. Cue Health (NASDAQ:HLTH)

March 31, 2023 | americanbankingnews.com

Standard BioTools (NASDAQ:LAB) & Cue Health (NASDAQ:HLTH) Financial Contrast

March 21, 2023 | markets.businessinsider.com

Cue Health Receives Emergency Use Authorization For Molecular Test To Detect Mpox

March 20, 2023 | finance.yahoo.com

Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test

March 17, 2023 | markets.businessinsider.com

BTIG Sticks to Their Buy Rating for Cue Health (HLTH)

March 16, 2023 | msn.com

Cue Health Earnings Perspective: Return On Invested Capital

March 16, 2023 | markets.businessinsider.com

Morgan Stanley Keeps Their Hold Rating on Cue Health (HLTH)

See More Headlines

HLTH Price History

30 days | 90 days | 365 days | Advanced Chart

HLTH Company Calendar

Last Earnings: 5/10/2023
Today: 6/06/2023
Next Earnings (Estimated): 8/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:HLTH
CUSIP: N/A
CIK: 1628945
Web: www.cuehealth.com
Phone: 858-412-8151
Fax: N/A
Employees: 1,515
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $6.20
High Stock Price Forecast: $8.00
Low Stock Price Forecast: $3.00
Forecasted Upside/Downside: +959.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.95)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-194,060,000.00
Net Margins: -88.51%
Pretax Margin: -91.48%
Return on Equity: -46.48%
Return on Assets: -35.18%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.25
Quick Ratio: 3.04

Sales & Book Value

Annual Sales: $483.48 million
Price / Sales: 0.18
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.86 per share
Price / Book: 0.15

Miscellaneous

Outstanding Shares: 151,620,000
Free Float: 132,667,000
Market Cap: $88.70 million
Optionable: Optionable
Beta: 1.43

Key Executives

Mr. Ayub K. Khattak (Age 37)
Co-Founder, Pres, CEO & Chairman
Comp: $9.4M

Mr. Clint Sever (Age 37)
Co-Founder & Chief Product Officer
Comp: $4.35M

Mr. Christopher K. Achar (Age 36)
Chief Strategy Officer & Director
Comp: $200.82k

Mr. John E. Gallagher (Age 49)
Chief Financial Officer

Mr. David Arida
Chief Operating Officer

Ms. Lorna Williams
VP of Investor Relations

Ms. Erica Palsis Esq. (Age 37)
Gen. Counsel & Corp. Sec.

Ms. Dena Cook
Chief Communications Officer

Ms. Eileen Sheil
Chief Communications Officer

Mr. Nitin Duggal
Chief Marketing Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HLTH Stock - Frequently Asked Questions

Should I buy or sell Cue Health stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cue Health in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HLTH shares.
View HLTH analyst ratings or view top-rated stocks.
What is Cue Health's stock price forecast for 2023?: 4 Wall Street research analysts have issued 12 month price targets for Cue Health's shares. Their HLTH share price forecasts range from $3.00 to $8.00. On average, they predict the company's share price to reach $6.20 in the next year. This suggests a possible upside of 959.8% from the stock's current price.
View analysts price targets for HLTH or view top-rated stocks among Wall Street analysts.
How have HLTH shares performed in 2023?: Cue Health's stock was trading at $2.07 at the beginning of the year. Since then, HLTH stock has decreased by 71.7% and is now trading at $0.5850.
View the best growth stocks for 2023 here.
When is Cue Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our HLTH earnings forecast.
How were Cue Health's earnings last quarter?: Cue Health Inc. (NASDAQ:HLTH) released its quarterly earnings data on Wednesday, May, 10th. The company reported ($0.48) EPS for the quarter, topping analysts' consensus estimates of ($0.61) by $0.13. The company had revenue of $24.77 million for the quarter. Cue Health had a negative trailing twelve-month return on equity of 46.48% and a negative net margin of 88.51%.
What ETFs hold Cue Health's stock?: ETFs with the largest weight of Cue Health (NASDAQ:HLTH) stock in their portfolio include ETFMG Treatments Testing and Advancements ETF (GERM), Janus Henderson Small Cap Growth Alpha ETF (JSML), Global X Telemedicine & Digital Health ETF (EDOC), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD),
What guidance has Cue Health issued on next quarter's earnings?: Cue Health updated its second quarter 2023 earnings guidance on Friday, May, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $8.00 million-$10.00 million, compared to the consensus revenue estimate of $20.98 million.

When did Cue Health IPO?: (HLTH) raised $200 million in an initial public offering on Friday, September 24th 2021. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share.
What is Cue Health's stock symbol?: Cue Health trades on the NASDAQ under the ticker symbol "HLTH."
Who are Cue Health's major shareholders?: Cue Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (4.38%), State Street Corp (1.44%), Geode Capital Management LLC (1.30%), Janney Montgomery Scott LLC (0.26%), AQR Capital Management LLC (0.24%) and Strs Ohio (0.17%).
View institutional ownership trends.
How do I buy shares of Cue Health?: Shares of HLTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cue Health's stock price today?: One share of HLTH stock can currently be purchased for approximately $0.59.
How much money does Cue Health make?: Cue Health (NASDAQ:HLTH) has a market capitalization of $88.70 million and generates $483.48 million in revenue each year. The company earns $-194,060,000.00 in net income (profit) each year or ($1.95) on an earnings per share basis.
How many employees does Cue Health have?: The company employs 1,515 workers across the globe.
How can I contact Cue Health?: Cue Health's mailing address is 4980 CARROLL CANYON ROAD SUITE 100, SAN DIEGO CA, 92121. The official website for the company is www.cuehealth.com. The company can be reached via phone at 858-412-8151 or via email at ir@cuehealth.com.

This page (NASDAQ:HLTH) was last updated on 6/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial